Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Langar Global HealthTech ETF (LGHT) belongs to the Healthcare Technology segment. First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. LGHT is more expensive with a Total Expense Ratio (TER) of 0.85%, versus 0.54% for FBT. LGHT is down -8.11% year-to-date (YTD) with - in YTD flows. FBT performs better with -5.96% YTD performance, and +$1.10B in YTD flows. Run a side-by-side ETF comparison of LGHT and FBT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LGHT FBT | -3.87%-5.58% | -8.66%-7.34% | -8.11%-5.96% | -8.02%+15.04% | n/a+29.35% | n/a+20.07% |
| Flows | LGHT FBT | -+$11M | -$101K+$1.10B | -+$1.10B | +$1M+$1.09B | -+$639M | -+$246M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LGHT FBT | +18.35%+22.00% | +21.19%+24.20% | n/a+19.85% | n/a+21.81% |
| Max drawdown | LGHT FBT | -12.49%-12.74% | -13.88%-14.81% | n/a-19.92% | n/a-29.98% |
| Max drawdown duration | LGHT FBT | 63d49d | 135d148d | n/a237d | n/a1243d |
LGHT | FBT | |
Last sale 3/12/2026 at 1:30 PM | $8.96 | $192.63 |
| Previous close 03/12/2026 | $9.19 | $193.57 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
LGHT | FBT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
LGHT | FBT | |
|---|---|---|
| Last price | $8.96 | $192.63 |
| 1D performance | -2.49% | -0.49% |
| AuM | $3.67 M | $2.22 B |
| E/R | 0.85% | 0.54% |
LGHT | FBT | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Langar Investment Management | First Trust |
| Benchmark | - | NYSE Arca Biotechnology Index |
| N° of holdings | 25 | 28 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 10, 2024 | June 19, 2006 |
| ESG | Yes | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
